MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3

FEBS Letters

Volumn 586, Issue 6, 2012, Pages 884-891

  Huang, Na ^a   Lin, Jing ^a,b   Ruan, Jian ^a   Su, Ning ^c   Qing, Ruzhai ^a   Liu, Feiye ^a   He, Benfu ^a   Lv, Chengwei ^a   Zheng, Dayong ^a   Luo, Rongcheng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SHANTOU UNIVERSITY   (China)

^c GUANGZHOU CHEST HOSPITAL   (China)

Author keywords

Cell proliferation; Glypican 3; Hepatocellular carcinoma; miR 219 5p; miRNA

Indexed keywords

GLYPICAN 3; MESSENGER RNA; MICRORNA; MICRORNA 219 5P; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION REGULATION; GPC3 GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA EXTRACTION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; SURVIVAL RATE;

EID: 84862794317     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.02.017     Document Type: Article

References (33)

1. El-Serag, H.B. (2011) Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118-1127.
2. Milazzo, M., Fornari, F. and Gramantieri, L. (2011) MicroRNA and hepatocellular carcinoma: biology and prognostic significance. Minerva. Gastroenterol. Dietol. 57, 257-271.
3. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Hwang, H.W. and Mendell, J.T. (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 94, 776-780.
5. Zhang, J., Yang, Y., Yang, T., Liu, Y., Li, A., Fu, S., Wu, M., Pan, Z. and Zhou, W. (2010) MicroRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer 103, 1215-1220.
6. Wang, C.M., Wang, Y., Fan, C.G., Xu, F.F., Sun, W.S., Liu, Y.G. and Jia, J.H. (2011) MiR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 411, 586-592.
7. Su, H., Yang, J.R., Xu, T., Huang, J., Xu, L., Yuan, Y. and Zhuang, S.M. (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69, 1135-1142.
8. Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C.G., Calin, G.A., Giovannini, C., Ferrazzi, E., Grazi, G.L., Croce, C.M., Bolondi, L. and Negrini, M. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 67, 6092-6099. (Pubitemid 47037488)
9. Zheng, F., Liao, Y.J., Cai, M.Y., Liu, Y.H., Liu, T.H., Chen, S.P., Bian, X.Y., Guan, X.Y., Lin, M.C., Zeng, Y.X., Kung, H.F. and Xie, D. (2011) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61, 278-289.
10. Liang, L., Wong, C.M., Ying, Q., Fan, D.N., Huang, S., Ding, J., Yao, J., Yan, M., Li, J., Yao, M., Ng, I.O. and He, X. (2010) MicroRNA-125b suppressed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 52, 1731-1740.
11. Wu, L., Cai, C., Wang, X., Liu, M., Li, X. and Tang, H. (2011) MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 585, 1322-1330.
12. Hou, Y.Y., Cao, W.W., Li, L., Li, S.P., Liu, T., Wan, H.Y., Liu, M., Li, X. and Tang, H. (2011) MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett. 307, 182-190.
13. Zhang, J.F., He, M.L., Fu, W.M., Wang, H., Chen, L.Z., Zhu, X., Chen, Y., Xie, D., Lai, P., Chen, G., Lu, G., Lin, M.C. and Kung, H.F. (2011) Primate-specific miRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting stat3 signaling. Hepatology 54, 2137-2148.
14. He, X.X., Chang, Y., Meng, F.Y., Wang, M.Y., Xie, Q.H., Tang, F., Li, P.Y., Song, Y.H., and Lin, J.S. (2011). MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. doi:10.1038/onc.2011.500.
15. Xu, Y., Xia, F., Ma, L., Shan, J., Shen, J., Yang, Z., Liu, J., Cui, Y., Bian, X., Bie, P. and Qian, C. (2011) MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett. 310, 160-169.
16. Kong, G., Zhang, J., Zhang, S., Shan, C., Ye, L. and Zhang, X. (2011) Upregulated MicroRNA-29a by Hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 6, e19518.
17. Elyakim, E., Sitbon, E., Faerman, A., Tabak, S., Montia, E., Belanis, L., Dov, A., Marcusson, E.G., Bennett, C.F., Chajut, A., Cohen, D. and Yerushalmi, N. (2010) Hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res. 70, 8077-8087.
18. Hou, J., Lin, L., Zhou, W., Wang, Z., Ding, G., Dong, Q., Qin, L., Wu, X., Zheng, Y., Yang, Y., Tian, W., Zhang, Q., Wang, C., Zhang, Q., Zhuang, S.M., Zheng, L., Liang, A., Tao, W. and Cao, X. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19, 232-243.
19. Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., Mazzaferro, V., Lowe, S.W., Croce, C.M. and Dejean, A. (2010) MiR-221 overexpression contributes to liver tumorigenesis. Proc. Natl. Acad. Sci. USA 107, 264-269.
20. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A., Downing, J.R., Jacks, T., Horvitz, H.R. and Golub, T.R. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838. (Pubitemid 40839735)
21. Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R.L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C.C. and Croce, C.M. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261. (Pubitemid 43271657)
22. Wong, T.S., Liu, X.B., Wong, B.Y., Ng, R.W., Yuen, A.P. and Wei, W.I. (2008) Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 14, 2588-2592.
23. Ferretti, E., De Smaele, E., Po, A., Di Marcotullio, L., Tosi, E., Espinola, M.S., Di Rocco, C., Riccardi, R., Giangaspero, F., Farcomeni, A., Nofroni, I., Laneve, P., Gioia, U., Caffarelli, E., Bozzoni, I., Screpanti, I. and Gulino, A. (2009) MicroRNA profiling in human medulloblastoma. Int. J. Cancer 124, 568-577.
24. Izzotti, A., Calin, G.A., Arrigo, P., Steele, V.E., Croce, C.M. and De Flora, S. (2009) Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 23, 806-812.
25. Ura, S., Honda, M., Yamashita, T., Ueda, T., Takatori, H., Nishino, R., Sunakozaka, H., Sakai, Y., Horimoto, K. and Kaneko, S. (2009) Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49, 1098-1112.
26. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. (Pubitemid 34164012)
27. Song, Y.X., Yue, Z.Y., Wang, Z.N., Xu, Y.Y., Luo, Y., Xu, H.M., Zhang, X., Jiang, L., Xing, C.Z. and Zhang, Y. (2011) MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol. Cancer 10, 1.
28. Ruan, J., Liu, F., Chen, X., Zhao, P., Su, N., Xie, G., Chen, J., Zheng, D. and Luo, R. (2011) Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line. Int. J. Mol. Med. 28, 497-503.
29. Ning, S., Bin, C., Na, H., Peng, S., Yi, D., Xiang-hua, Y., Fang-yin, Z., Da-yong, Z. and Rong-cheng, L. (2012) Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients. Mol. Biol. Rep. 39, 351-357.
30. Dugas, J.C., Cuellar, T.L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J.L., Foo, L.C.,McManus,M.T. and Barres, B.A. (2010) Dicer1 andmiR-219 Are required for normal oligodendrocyte differentiation andmyelination. Neuron 65, 597-611.
31. Ho, M. and Kim, H. (2011) Glypican-3: a new target for cancer immunotherapy. Eur. J. Cancer 47, 333-338.
32. Capurro, M.I., Xiang, Y.Y., Lobe, C. and Filmus, J. (2005) Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res. 65, 6245-6254. (Pubitemid 40994410)
33. Jalvy-Delvaille, S., Maurel, M., Majo, V., Pierre, N., Chabas, S., Combe, C., Rosenbaum, J., Sagliocco, F., and Grosset, C.F. (2011). Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model. Nucleic Acids Res. doi:10.1093/nar/qkr843.